PAPER Mouzon BC, Bachmeier C, Ferro A, Ojo JO, Crynen G, Acker CM, Davies P, Mullan M, Stewart W, Crawford F
SEARCH RESULTS
330988 RESULTS
PAPER Baudrexel S, Seifried C, Penndorf B, Klein JC, Middendorp M, Steinmetz H, Grünwald F, Hilker R
The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy.
Mov Disord. 2014 Mar;29(3):380-7. Epub 2013 Nov 15 PubMed: 24243813PAPER Recasens A, Dehay B, Bové J, Carballo-Carbajal I, Dovero S, Pérez-Villalba A, Fernagut PO, Blesa J, Parent A, Perier C, Fariñas I, Obeso JA, Bezard E, Vila M
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.
Ann Neurol. 2014 Mar;75(3):351-62. Epub 2014 Feb 18 PubMed: 24243558PAPER Matsuura S, Shuvaev AN, Iizuka A, Nakamura K, Hirai H
Mesenchymal stem cells ameliorate cerebellar pathology in a mouse model of spinocerebellar ataxia type 1.
Cerebellum. 2014 Jun;13(3):323-30. PubMed: 24242763PAPER Healy EF, Little C, King PJ
A model for small heat shock protein inhibition of polyglutamine aggregation.
Cell Biochem Biophys. 2014 Jun;69(2):275-81. PubMed: 24242192PAPER Deng J, Qi XL, Guan ZZ, Yan XM, Huang Y, Wang YL
Pretreatment of SH-SY5Y cells with dicaffeoylquinic acids attenuates the reduced expression of nicotinic receptors, elevated level of oxidative stress and enhanced apoptosis caused by β-amyloid peptide.
J Pharm Pharmacol. 2013 Dec;65(12):1736-44. Epub 2013 Aug 5 PubMed: 24236983PAPER
Strengthening connections between Down syndrome and AD.
Biochim Biophys Acta. 2013 Sep 17; PubMed: 24050729PAPER De Felice FG
Connecting type 2 diabetes to Alzheimer's disease.
Expert Rev Neurother. 2013 Dec;13(12):1297-9. PubMed: 24236899PAPER Lloyd M, Mokdsi G, Spielthenner D
Clearing the fog: patenting trends for the treatment of Alzheimer's disease.
Pharm Pat Anal. 2012 Sep;1(4):437-55. PubMed: 24236882PAPER Xiao J, Tundis R
Natural products for Alzheimer's disease therapy: basic and application.
J Pharm Pharmacol. 2013 Dec;65(12):1679-80. PubMed: 24236979PAPER Pinho BR, Ferreres F, Valentão P, Andrade PB
Nature as a source of metabolites with cholinesterase-inhibitory activity: an approach to Alzheimer's disease treatment.
J Pharm Pharmacol. 2013 Dec;65(12):1681-700. Epub 2013 May 16 PubMed: 24236980PAPER Konrath EL, Passos Cd, Klein LC Jr, Henriques AT
Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease.
J Pharm Pharmacol. 2013 Dec;65(12):1701-25. Epub 2013 Jun 20 PubMed: 24236981PAPER Du J, Liang Y, Xu F, Sun B, Wang Z
Trehalose rescues Alzheimer's disease phenotypes in APP/PS1 transgenic mice.
J Pharm Pharmacol. 2013 Dec;65(12):1753-6. Epub 2013 Aug 5 PubMed: 24236985PAPER Li X, Li TQ, Andreasen N, Wiberg MK, Westman E, Wahlund LO
The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
J Intern Med. 2014 Apr;275(4):418-27. Epub 2013 Dec 11 PubMed: 24237038PAPER Guo K, Janigro D
New immunological approaches in treating and diagnosing CNS diseases.
Pharm Pat Anal. 2013 May;2(3):361-71. PubMed: 24237062Current Filters
No filters selected